Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2008 3
2009 5
2010 2
2011 2
2012 3
2013 7
2014 3
2015 4
2016 8
2017 8
2018 4
2019 11
2020 18
2021 9
2022 21
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility.
MacIsaac MB, Whitton B, Anderson J, Cogger S, Vella-Horne D, Penn M, Weeks A, Elmore K, Pemberton D, Winter RJ, Papaluca T, Howell J, Hellard M, Stoové M, Wilson D, Pedrana A, Doyle JS, Clark N, Holmes JA, Thompson AJ. MacIsaac MB, et al. Among authors: howell j. Int J Drug Policy. 2024 Mar;125:104317. doi: 10.1016/j.drugpo.2024.104317. Epub 2024 Jan 28. Int J Drug Policy. 2024. PMID: 38281385
Pathway to global elimination of hepatitis B: HBV cure is just the first step.
Howell J, Seaman C, Wallace J, Xiao Y, Scott N, Davies J, de Santis T, Adda D, El-Sayed M, Feld JJ, Gane E, Lacombe K, Lesi O, Mohamed R, Silva M, Tu T, Revill P, Hellard ME. Howell J, et al. Hepatology. 2023 Sep 1;78(3):976-990. doi: 10.1097/HEP.0000000000000430. Epub 2023 May 1. Hepatology. 2023. PMID: 37125643 Free PMC article. Review.
Validation of novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study.
Howell J, Van H, Pham M, Sawhney R, Li F, Bhat P, Lubel J, Kemp W, Bloom S, Majumdar A, McCaughan G, Hall S, Spelman T, Doyle JS, Hellard M, Visvanathan K, Thompson AJ, Drummer HE, Anderson D. Howell J, et al. Clin Liver Dis (Hoboken). 2022 Oct 10;20(4):136-139. doi: 10.1002/cld.1261. eCollection 2022 Oct. Clin Liver Dis (Hoboken). 2022. PMID: 36245683 Free PMC article. No abstract available.
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study.
Howell J, Samani A, Mannan B, Hajiev S, Motedayen Aval L, Abdelmalak R, Tam VC, Bettinger D, Thimme R, Taddei TH, Kaplan DE, Seidensticker M, Sharma R. Howell J, et al. Therap Adv Gastroenterol. 2022 Sep 30;15:17562848221100106. doi: 10.1177/17562848221100106. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36199289 Free PMC article.
Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study.
Patwala K, Prince DS, Celermajer Y, Alam W, Paul E, Strasser SI, McCaughan GW, Gow P, Sood S, Murphy E, Roberts S, Freeman E, Stratton E, Davison SA, Levy MT, Clark-Dickson M, Nguyen V, Bell S, Nicoll A, Bloom A, Lee AU, Ryan M, Howell J, Valaydon Z, Mack A, Liu K, Dev A. Patwala K, et al. Among authors: howell j. Hepatol Int. 2022 Oct;16(5):1170-1178. doi: 10.1007/s12072-022-10398-5. Epub 2022 Aug 25. Hepatol Int. 2022. PMID: 36006547 Free PMC article.
107 results